US5158975A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Use of stearidonic acid
Assignee: Nestec SA
•
Filing: 1991-04-24
•
Granted: 1992-10-27
•
Expires: 2011-04-24
Abstract
Abstract Stearidonic acid is administered to mammals for inhibiting biosynthesis of leukotrienes.
Inventors
- 👤 Michel Guichardant
- 👤 Michel Rigaud
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 08:26
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/185; A61K31/19; A61K31/20; A61K35/00; A61K35/56; A61K35/60; A61P; A61P17/00; A61P29/00; A61P37/00; A61P37/08; A61P43/00; A61P9/00
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
31 words
A method for treatment of disorders of inflammatory origin comprising administering stearidonic acid orally to a mammal in need of such treatment in an amount effective for inhibiting biosynthesis of leukotrienes.
Claim 2
Independent Claim
31 words
A method for treatment of disorders of inflammatory origin comprising administering stearidonic acid orally to a mammal in need of such treatment in an amount effective for inhibiting biosynthesis of leukotrienes.
Claim 3
Independent Claim
31 words
A method for treatment of disorders of inflammatory origin comprising administering stearidonic acid rectally to a mammal in need of such treatment in an amount effective for inhibiting biosynthesis of leukotrienes.
Claim 4
Independent Claim
31 words
A method for treatment of disorders of inflammatory origin comprising administering stearidonic acid rectally to a mammal in need of such treatment in an amount effective for inhibiting biosynthesis of leukotrienes.
Claim 5
Independent Claim
31 words
A method for treatment of disorders of inflammatory origin comprising administering stearidonic acid enterally to a mammal in need of such treatment in an amount effective for inhibiting biosynthesis of leukotrienes.
Claim 6
Independent Claim
31 words
A method for treatment of disorders of inflammatory origin comprising administering stearidonic acid enterally to a mammal in need of such treatment in an amount effective for inhibiting biosynthesis of leukotrienes.
Claim 7
Independent Claim
31 words
A method for treatment of disorders of inflammatory origin comprising administering stearidonic acid parenterally to a mammal in need of such treatment in an amount effective for inhibiting biosynthesis of leukotrienes.
Claim 8
Independent Claim
31 words
A method for treatment of disorders of inflammatory origin comprising administering stearidonic acid parenterally to a mammal in need of such treatment in an amount effective for inhibiting biosynthesis of leukotrienes.
Claim 9
Dependent Claim
35 words
A method according to claim 1 or 2 or 3 or 4 wherein the stearidonic acid is in a form selected from a group consisting of pharmaceutically acceptable salts, esters and amides of stearidonic acid.
Claim 10
Dependent Claim
34 words
A method according to claim 1 or 2 or 3 or 4 wherein the stearidonic acid is administered in a daily dose of an amount of from 0.5 g to 10 g stearidonic acid.
Claim 11
Dependent Claim
31 words
A method according to claim 1 or 2 or 3 or 4 further comprising administering the stearidonic acid with at least one fatty acid which inhibits oxygenated metabolism of arachadonic acid.
Claim 12
Dependent Claim
31 words
A method according to claim 7 wherein the at least one fatty acid is selected from the group of fatty acids consisting of eieosapentaenoic acid, and docosahexaenoic acid and combinations thereof.
Claim 13
Dependent Claim
28 words
A method according to claim 7 wherein the at least one fatty acid is selected from the group of fatty acids consisting of γ-linolenic acid and idihomo-γ-linolenic acid.
References Cited (Backward Citations)
EP0347056B1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-10-27 | 1996-04-27 | 1996-10-27 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-10-27 | 2000-04-27 | 2000-10-27 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-10-27 | 2004-04-27 | 2004-10-27 | $7700.00 | Window Closed / Lapsed |